Cavallo Ventures
VC Fund
San Francisco, United States
Cavallo Ventures is a venture capital firm that focuses on feed, pet nutrition, aquafeed, ingredients, and formulation. They invest their own capital and are looking for pioneering entrepreneurs that insist on building successful companies without taking shortcuts. Cavallo Ventures was founded in 2016 and is based in San Francisco, California.
- Total investments:
- 56
- Last investment:
- Lead investor:
- 13%
Last updated:
For AI agents: llms.txt
Industries Cavallo Ventures invests in
Stages Cavallo Ventures invests in
Countries Cavallo Ventures invests in
Round sizes
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Round size
- Seed
- $1.4M–$11M
- Series A
- $4.5M–$47M
- Series B
- $8M–$45M
Investment Focus
Industry
- Agriculture 17 (30%)
- Biotechnology 14 (25%)
- AgTech 12 (21%)
- Farming 9 (16%)
- Software 6 (11%)
Stage
- Series A 16 (29%)
- Seed 14 (25%)
- Series B 9 (16%)
- Funding Round 3 (5%)
- Series C 2 (4%)
Country
- United States 28 (50%)
- Canada 1 (2%)
- Israel 1 (2%)
- Mexico 1 (2%)
- Australia 1 (2%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
|
Amar Singh
Director
|
Director | Total investments: 5 | Find email | |
Matt Miller
Investor
|
Investor | Total investments: 0 | Find email | |
Michael Wilbur
President & CEO
|
President & CEO | Total investments: 0 | Find email | |
Michael Wilbur
President & CEO
|
President & CEO | Total investments: 4 | Find email | |
Son V.
Managing Director
|
Managing Director | Total investments: 4 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Agtonomy
|
Agtonomy is a hybrid autonomy and tele-assist platform for agriculture vehicles. | $10M / Series A / Oct 16, 2024 | |
AgroSpheres
|
AgroSpheres develops novel technologies that aim to set a new standard for bio-based delivery of active ingredients. It uses a unique platform technology for crop protection solutions and other industrial applications. The company is an encapsulation and delivery technology that dramatically enhances the performance of a broad range of cropprotection products including fungicides, insecticides, and herbicides.AgroSpheres was founded in 2016 and is based in Charlottesville, Virginia. | $12M / Series B / Sep 30, 2024 | |
Solasta Bio
|
Solasta Bio develops environment-friendly products that meet a global need for new and effective crop protection. | $14M / Series A / Sep 11, 2024 | |
Kuehnle Agrosystems
|
Kuehnle Agrosystems, Inc. conducts biotech research and development of plant-based systems for production of biologically active compounds. The company was formerly known as Kuehnle Agrosystems Company, LLC. The company was incorporated in 2007 and is based in Honolulu, Hawaii. | $3M / Series A / Mar 13, 2024 | |
Zymochem
|
The world they live in is built from petroleum. The paints on their walls, the carpets in their homes, the tires on their cars, the plastics for everyday consumer goods – these and many more products are made from chemicals that are mostly made from petroleum, creating a $3 trillion/yr industry. To fulfill their dependency on petroleum, theydo crazy things like setting up oil rigs in the middle of the ocean and drilling several miles into the ocean floor! They’ve done these things because they have had no alternative to meet their needs. Not anymore!Over the past decade, advances in engineering microorganisms have afforded us the opportunity to make the same chemicals that are traditionally made from petroleum. Instead of requiring raw materials buried deep within the earth, microbes can use abundant and renewable sources of carbon such as sugars during processes akin to brewing beer. Despite the numerous advantages, making chemicals this way at the industrial level is still rare. This is because it’s still more expensive than using petroleum for producing the chemicals. Although a few challenges need to be solved to usher in the era of renewable chemicals, a fundamental constraint that limits the economic competitiveness of using microbes is the loss of at least 33% of the carbon as carbon dioxide waste during the fermentation – think of this as the head on your beer. Because of this carbon loss, potential product is simply not made. In technical terms, the maximum achievable yields are 67%. As sugars are the most expensive component of a bioprocess, making the carbon dioxide waste translates to as much as 20% of total costs, which severely hampers the economics of the bioprocess and its competitiveness with petroleum-based production methods.At ZymoChem, they are re-imagining the microbe, one that is designed to eliminate (or substantially reduce) carbon loss during the production of chemicals. To do this, they had to design a completely new biosynthetic pathway – one that doesn’t exist in nature – to make the chemicals. Each individual step of this pathway is designed to not lose carbon as carbon dioxide, enabling their biosynthetic pathway to retain all of the sugar’s carbon into the final chemical product. This carbon conservation allows their approach to have superior theoretical yields, up to 50% better than existing state-of-the-art technology! In turn, their technology has the potential to substantially lower production costs and drastically improve cost-competitiveness for making a variety of chemicals from renewable sources, even at today's oil prices. | $21M / Series A / Jan 15, 2024 | |
|
AgroSpheres
|
AgroSpheres develops novel technologies that aim to set a new standard for bio-based delivery of active ingredients. It uses a unique platform technology for crop protection solutions and other industrial applications. The company is an encapsulation and delivery technology that dramatically enhances the performance of a broad range of cropprotection products including fungicides, insecticides, and herbicides.AgroSpheres was founded in 2016 and is based in Charlottesville, Virginia. | $3M / Series B / Nov 27, 2023 | |
Talus Renewables
|
Talus Renewables offers new pathways to chemicals, fertilizers, and fuels with its green ammonia production technology. | $22M / Series A / Nov 02, 2023 | |
Debut
|
Debut Biotech develops biotechnology-based beauty ingredients and formulations in a vertically integrated manner, beginning with AI-powered discovery and continuing through biosynthesis, biomanufacturing, downstream processing, and finished formulations. The company utilizes its BeautyORB platform to computationally screen vast chemical librariesand predict novel bioactives, which then proceed through validation, safety testing, and formulation for skincare and haircare applications. Debut employs both engineered microbial fermentation and cell-free enzymatic systems to produce these novel ingredients sustainably and then transitions them into proprietary formulations or custom white-label products. | $34M / Series B / Jun 01, 2023 | |
|
Debut
|
Debut Biotech develops biotechnology-based beauty ingredients and formulations in a vertically integrated manner, beginning with AI-powered discovery and continuing through biosynthesis, biomanufacturing, downstream processing, and finished formulations. The company utilizes its BeautyORB platform to computationally screen vast chemical librariesand predict novel bioactives, which then proceed through validation, safety testing, and formulation for skincare and haircare applications. Debut employs both engineered microbial fermentation and cell-free enzymatic systems to produce these novel ingredients sustainably and then transitions them into proprietary formulations or custom white-label products. | $40M / Series B / Jun 01, 2023 | |
|
Solasta Bio
|
Solasta Bio develops environment-friendly products that meet a global need for new and effective crop protection. | $4.9M / Seed / Mar 27, 2023 | |
| See all 56 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar stage
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does Cavallo Ventures invest in?
Cavallo Ventures invests primarily in Agriculture, Biotechnology and AgTech startups, most often at Series A and Seed stage. Most of the 56 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is Cavallo Ventures's check size?
Cavallo Ventures typically joins rounds of $1.4M–$11M at Seed, $4.5M–$47M at Series A and $8M–$45M at Series B. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Cavallo Ventures participates in.
How do I contact Cavallo Ventures?
Public channels for Cavallo Ventures include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Cavallo Ventures?
The team at Cavallo Ventures includes Amar Singh (Director), Matt Miller (Investor) and Michael Wilbur (President & CEO). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
